Primary Recipient

ORGANIX INCORPORATED

Amount

$96,281.00

Award Date

1/18/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The overall scope of our Phase Two SBIR project has been to design, synthesize, and develop novel and patentable 5-HT2C-selective indole derivatives leading to the development of a clinical candidate to treat obesity, and ultimately to the approval of thi